No animal study can predict with complete certainty how a therapy will perform in human subjects, but it is PharmaLegacy’s job to ensure that you come as close to certainty as possible. While utilization of non-human primate (NHP) models is a step in the right direction, you need to ensure you are using are designed to provide the most physiologically relevant models possible.
Take rheumatoid arthritis (RA), for example. There are multiple NHP models for rheumatoid arthritis, but you still need to decide what species and what model will perform best for your studies. Download our NHP models brochure for a primer on model selection for RA.
Some of the many reasons to partner with PharmaLegacy:
NHP Models covering over a dozen disease areas
On-site capacity for up to 350 primates
Total capacity for up to 30,000 primates
Bespoke models available upon request
To advance a compound from discovery to clinical, or to halt its development, is a huge and costly decision. For the benefit of you and your company, and for the well-being of patients in need of treatment, that decision needs to be based on correct information. Learn how PharmaLegacy can help you get the correct answers using our NHP models.